AU7211287A - Creación de Inventos y Patentes con Inteligencia Artificial

AU7211287A – Controlled release drug delivery system for the peridontal pocket
– Google Patents

AU7211287A – Controlled release drug delivery system for the peridontal pocket
– Google Patents
Controlled release drug delivery system for the peridontal pocket

Info

Publication number
AU7211287A

AU7211287A
AU72112/87A
AU7211287A
AU7211287A
AU 7211287 A
AU7211287 A
AU 7211287A
AU 72112/87 A
AU72112/87 A
AU 72112/87A
AU 7211287 A
AU7211287 A
AU 7211287A
AU 7211287 A
AU7211287 A
AU 7211287A
Authority
AU
Australia
Prior art keywords
delivery system
drug delivery
controlled release
release drug
peridontal
Prior art date
1986-04-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Application number
AU72112/87A
Other versions

AU614061B2
(en

Inventor
Richard W. Baker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Flora Inc

Original Assignee
PharMetrix Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1986-04-29
Filing date
1987-04-27
Publication date
1987-11-05
Family has litigation

First worldwide family litigation filed
litigation
Critical
https://patents.darts-ip.com/?family=25324860&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU7211287(A)
«Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1987-04-27
Application filed by PharMetrix Corp
filed
Critical
PharMetrix Corp

1987-11-05
Publication of AU7211287A
publication
Critical
patent/AU7211287A/en

1991-08-22
Application granted
granted
Critical

1991-08-22
Publication of AU614061B2
publication
Critical
patent/AU614061B2/en

1997-04-17
Assigned to FLORA INC.
reassignment
FLORA INC.
Request to Amend Deed and Register
Assignors: PHARMETRIX CORPORATION

2007-04-27
Anticipated expiration
legal-status
Critical

Status
Ceased
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction

A61K9/1605—Excipients; Inactive ingredients

A61K9/1629—Organic macromolecular compounds

A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K6/00—Preparations for dentistry

A61K6/15—Compositions characterised by their physical properties

A61K6/17—Particle size

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K6/00—Preparations for dentistry

A61K6/30—Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K6/00—Preparations for dentistry

A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives

A61K6/69—Medicaments

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/0012—Galenical forms characterised by the site of application

A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

A61K9/0063—Periodont

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

A61K9/1605—Excipients; Inactive ingredients

A61K9/1629—Organic macromolecular compounds

A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

A61K9/1605—Excipients; Inactive ingredients

A61K9/1629—Organic macromolecular compounds

A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers

A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

AU72112/87A
1986-04-29
1987-04-27
Controlled release drug delivery system for the peridontal pocket

Ceased

AU614061B2
(en)

Applications Claiming Priority (2)

Application Number
Priority Date
Filing Date
Title

US856961

1986-04-29

US06/856,961

US4780320A
(en)

1986-04-29
1986-04-29
Controlled release drug delivery system for the periodontal pocket

Publications (2)

Publication Number
Publication Date

AU7211287A
true

AU7211287A
(en)

1987-11-05

AU614061B2

AU614061B2
(en)

1991-08-22

Family
ID=25324860
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU72112/87A
Ceased

AU614061B2
(en)

1986-04-29
1987-04-27
Controlled release drug delivery system for the peridontal pocket

Country Status (10)

Country
Link

US
(1)

US4780320A
(en)

EP
(1)

EP0244118B1
(en)

JP
(1)

JP2698353B2
(en)

AU
(1)

AU614061B2
(en)

CA
(1)

CA1309345C
(en)

DE
(1)

DE3787829T2
(en)

DK
(1)

DK219287A
(en)

MX
(1)

MX167175B
(en)

NO
(1)

NO177125C
(en)

NZ
(1)

NZ219948A
(en)

Families Citing this family (136)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

JPS62223112A
(en)

1986-03-25
1987-10-01
Rooto Seiyaku Kk
Remedy for periodontosis

US5500228A
(en)

1987-05-26
1996-03-19
American Cyanamid Company
Phase separation-microencapsulated pharmaceuticals compositions useful for alleviating dental disease

US5013553A
(en)

1987-06-30
1991-05-07
Vipont Pharmaceutical, Inc.
Drug delivery devices

US5175000A
(en)

1987-06-30
1992-12-29
Vipont Pharmaceutical, Inc.
Free amine benzophenanthridine alkaloid compositions

US4843099A
(en)

1987-07-20
1989-06-27
Colgate-Palmolive Company
Device and composition for treatment of the gums

US4938763B1
(en)

1988-10-03
1995-07-04
Atrix Lab Inc
Biodegradable in-situ forming implants and method of producing the same

US5632727A
(en)

1988-10-03
1997-05-27
Atrix Laboratories, Inc.
Biodegradable film dressing and method for its formation

US5324520A
(en)

1988-12-19
1994-06-28
Vipont Pharmaceutical, Inc.
Intragingival delivery systems for treatment of periodontal disease

DE68915132T2
(en)

1988-12-22
1994-12-08
American Cyanamid Co

Process for the treatment of periodontitis by protracted drug delivery of medicinal products in the tooth cavity, composition thereof and device for administration.

DE68918419T2
(en)

1988-12-22
1995-05-04
American Cyanamid Co

Phase-encapsulated micro-encapsulated drug composition to reduce dental disease.

US5236355A
(en)

1988-12-22
1993-08-17
American Cyanamid Company
Apparatus for the treatment of periodontal disease

US5007790A
(en)

1989-04-11
1991-04-16
Depomed Systems, Inc.
Sustained-release oral drug dosage form

US5324519A
(en)

1989-07-24
1994-06-28
Atrix Laboratories, Inc.
Biodegradable polymer composition

US5487897A
(en)

1989-07-24
1996-01-30
Atrix Laboratories, Inc.
Biodegradable implant precursor

US5077049A
(en)

1989-07-24
1991-12-31
Vipont Pharmaceutical, Inc.
Biodegradable system for regenerating the periodontium

US5143934A
(en)

1990-11-21
1992-09-01
A/S Dumex (Dumex Ltd.)
Method and composition for controlled delivery of biologically active agents

US5198220A
(en)

1989-11-17
1993-03-30
The Procter & Gamble Company
Sustained release compositions for treating periodontal disease

US4997830A
(en)

1990-02-07
1991-03-05
The Research Foundation Of State University Of New York
Pharmaceutical composition for the treatment of periodontitis

US5464609A
(en)

1990-03-16
1995-11-07
The Procter & Gamble Company
Use of ketorolac for treatment of oral diseases and conditions

AU629316B2
(en)

1990-04-11
1992-10-01
Flora Inc.
Periodontal disease treatment system

USRE37950E1
(en)

1990-04-24
2002-12-31
Atrix Laboratories
Biogradable in-situ forming implants and methods of producing the same

US5197882A
(en)

1990-05-14
1993-03-30
Gary R. Jernberg
Periodontal barrier and method for aiding periodontal tissue regeneration agents

US5059123A
(en)

1990-05-14
1991-10-22
Jernberg Gary R
Periodontal barrier and method for aiding periodontal tissue regeneration

US5290271A
(en)

1990-05-14
1994-03-01
Jernberg Gary R
Surgical implant and method for controlled release of chemotherapeutic agents

WO1992000718A1
(en)

1990-07-03
1992-01-23
Vipont Pharmaceutical, Inc.
Intragingival delivery systems for treatment of periodontal disease

MX9101786A
(en)

1990-10-30
1992-06-05
Alza Corp

DRUG SUPPLY SYSTEM AND METHOD

US5620700A
(en)

1990-10-30
1997-04-15
Alza Corporation
Injectable drug delivery system and method

US5770588A
(en)

1991-02-11
1998-06-23
The Research Foundation Of State University Of New York
Non-antibacterial tetracycline compositions of the prevention and treatment of root caries

WO1993003649A1
(en)

1991-08-23
1993-03-04
Gillette Canada Inc.
Sustained-release martrices for dental application

US5340581A
(en)

1991-08-23
1994-08-23
Gillette Canada, Inc.
Sustained-release matrices for dental application

US5906834A
(en)

1992-06-15
1999-05-25
The Gillette Company
Color changing matrix as wear indicator

AU675206B2
(en)

1991-09-13
1997-01-30
Gillette Canada Inc.
Polymeric particles for dental applications

US5211939A
(en)

1991-09-13
1993-05-18
Gillette Canada
Method for desensitizing teeth

AU704007B2
(en)

1991-09-13
1999-04-01
Gillette Canada Inc.
Toothbrushes

US5250288A
(en)

1991-09-13
1993-10-05
Gillette Canada, Inc.
Method for desensitizing teeth

US5364634A
(en)

1991-11-08
1994-11-15
Southwest Research Institute
Controlled-release PH sensitive capsule and adhesive system and method

DE4140184C2
(en)

1991-12-05
1995-12-21
Alfatec Pharma Gmbh

Acute form for a medicine containing flurbiprofen

DE4140183C2
(en)

1991-12-05
1995-12-21
Alfatec Pharma Gmbh

Retard form for a medicine containing flurbiprofen

EP0560014A1
(en)

1992-03-12
1993-09-15
Atrix Laboratories, Inc.
Biodegradable film dressing and method for its formation

WO1993019739A1
(en)

1992-03-30
1993-10-14
Alza Corporation
Viscous suspensions of controlled-release drug particles

ZA932273B
(en)

1992-03-30
1993-11-26
Alza Corp
Additives for bioerodible polymers to regulate degradation

AU683022B2
(en)

1992-09-10
1997-10-30
Children’s Medical Center Corporation
Biodegradable polymer matrices for sustained delivery of local anesthetic agents

US5922340A
(en)

1992-09-10
1999-07-13
Children’s Medical Center Corporation
High load formulations and methods for providing prolonged local anesthesia

US5700485A
(en)

1992-09-10
1997-12-23
Children’s Medical Center Corporation
Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid

US5242910A
(en)

1992-10-13
1993-09-07
The Procter & Gamble Company
Sustained release compositions for treating periodontal disease

US5447725A
(en)

1993-06-11
1995-09-05
The Procter & Gamble Company
Methods for aiding periodontal tissue regeneration

WO1995001767A1
(en)

1993-07-08
1995-01-19
Cygnus Therapeutic Systems
Monolithic matrix transdermal delivery system

WO1995022308A1
(en)

1994-02-17
1995-08-24
The Oralife Group, Inc.
Method for the diagnosis and reduction of dental caries

US5502092A
(en)

1994-02-18
1996-03-26
Minnesota Mining And Manufacturing Company
Biocompatible porous matrix of bioabsorbable material

DE69530919T2
(en)

1994-04-08
2004-05-13
Atrix Laboratories, Inc., Fort Collins

ASSOCIATED POLYMER SYSTEM FOR USE WITH A MEDICAL DEVICE

DK1125577T3
(en)

1994-04-08
2006-06-19
Qlt Usa Inc

Liquid drug delivery preparations

US5725869A
(en)

1994-06-20
1998-03-10
Zeneca Limited
Microsphere reservoirs for controlled release application

US5616315A
(en)

1994-10-13
1997-04-01
Gillette Canada Inc.
Particles including degradable material and anti-microbial agent

US5660817A
(en)

1994-11-09
1997-08-26
Gillette Canada, Inc.
Desensitizing teeth with degradable particles

US5607686A
(en)

1994-11-22
1997-03-04
United States Surgical Corporation
Polymeric composition

US5779471A
(en)

1995-03-08
1998-07-14
Gillette Canada Inc.
Delivery of substance to the mouth

CA2195119C
(en)

1995-06-09
2001-09-11
Mark Chasin
Formulations and methods for providing prolonged local anesthesia

US5747060A
(en)

1996-03-26
1998-05-05
Euro-Celtique, S.A.
Prolonged local anesthesia with colchicine

SE9601421D0
(en)

1996-04-12
1996-04-12
Astra Ab

New composition

US5939047A
(en)

1996-04-16
1999-08-17
Jernberg; Gary R.
Local delivery of chemotherapeutic agents for treatment of periodontal disease

CN1126537C
(en)

1996-05-23
2003-11-05
株式会社三养社
Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof

AU733867B2
(en)

1996-06-24
2001-05-31
Euro-Celtique S.A.
Methods for providing safe local anesthesia

US6046187A
(en)

1996-09-16
2000-04-04
Children’s Medical Center Corporation
Formulations and methods for providing prolonged local anesthesia

US5972389A
(en)

1996-09-19
1999-10-26
Depomed, Inc.
Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter

US5918609A
(en)

1996-10-24
1999-07-06
Gillette Canada Inc.
Particulate modified elastomeric flosses

US5941256A
(en)

1996-12-24
1999-08-24
Gillette Canada Inc.
Dental hygiene article

ES2130969B1
(en)

1997-02-24
2000-02-16
Univ Valencia Estudi General

BIOMEMBRANES FOR EXTEMPORANEOUS ENCAPSULATION OF TETRACAINE.

EP1033127A4
(en)

1997-03-18
2006-07-26
Sunstar Inc
Composition for forming solid particles

FR2764514B1
(en)

1997-06-13
1999-09-03
Biopharmex Holding Sa

IMPLANT INJECTED IN SUBCUTANEOUS OR INTRADERMAL WITH CONTROLLED BIORESORBABILITY FOR REPAIR OR PLASTIC SURGERY AND AESTHETIC DERMATOLOGY

CA2271750C
(en)

1997-07-02
2004-04-27
Euro-Celtique, S.A.
Prolonged anesthesia in joints and body spaces

US6123957A
(en)

1997-07-16
2000-09-26
Jernberg; Gary R.
Delivery of agents and method for regeneration of periodontal tissues

US6153210A
(en)

1997-08-14
2000-11-28
Periodontix, Inc.
Use of locally delivered metal ions for treatment of periodontal disease

US7846919B2
(en)

1998-02-10
2010-12-07
Dermex Pharmaceuticals, Llc
Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions

US7128927B1
(en)

1998-04-14
2006-10-31
Qlt Usa, Inc.
Emulsions for in-situ delivery systems

US6451335B1
(en)

1998-07-02
2002-09-17
Euro-Celtique S.A.
Formulations and methods for providing prolonged local anesthesia

US6153225A
(en)

1998-08-13
2000-11-28
Elan Pharma International Limited
Injectable formulations of nanoparticulate naproxen

US6165506A
(en)

1998-09-04
2000-12-26
Elan Pharma International Ltd.
Solid dose form of nanoparticulate naproxen

US8226598B2
(en)

1999-09-24
2012-07-24
Tolmar Therapeutics, Inc.
Coupling syringe system and methods for obtaining a mixed composition

DE19957918A1
(en)

1999-11-25
2001-06-13
Ulrich Doht

Disinfectant cleaner for cleaning and care and process for its manufacture

US6555125B2
(en)

1999-11-30
2003-04-29
Phillip Campbell
Lesion and ulcer medication

US6352711B1
(en)

1999-11-30
2002-03-05
Phillip Campbell
Lesion and ulcer medication

US6503894B1
(en)

2000-08-30
2003-01-07
Unimed Pharmaceuticals, Inc.
Pharmaceutical composition and method for treating hypogonadism

US6565873B1
(en)

2000-10-25
2003-05-20
Salvona Llc
Biodegradable bioadhesive controlled release system of nano-particles for oral care products

US6887493B2
(en)

2000-10-25
2005-05-03
Adi Shefer
Multi component controlled release system for oral care, food products, nutraceutical, and beverages

US6589562B1
(en)

2000-10-25
2003-07-08
Salvona L.L.C.
Multicomponent biodegradable bioadhesive controlled release system for oral care products

US6576226B1
(en)

2000-11-17
2003-06-10
Gary R. Jernberg
Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease

US6726898B2
(en)

2000-11-17
2004-04-27
Gary R. Jernberg
Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease

US6610274B1
(en)

2000-12-22
2003-08-26
Wallace J. Gardner
Anti-inflammatory composition comprising tetracycline

US20040029842A1
(en)

2001-12-18
2004-02-12
Gardner Wallace J.
Triglyceride lowering, common cold and pneumonia prevention composition comprising tetracycline, and methods of treating or preventing diseases using same

JP4202656B2
(en)

2002-02-19
2008-12-24
サンスター株式会社

Topical sustained-release ointment

US7074426B2
(en)

2002-03-27
2006-07-11
Frank Kochinke
Methods and drug delivery systems for the treatment of orofacial diseases

US20040001889A1
(en)

2002-06-25
2004-01-01
Guohua Chen
Short duration depot formulations

CN101797221B
(en)

2002-12-13
2013-06-12
杜雷科特公司
Oral drug delivery system comprising high viscosity liquid carrier materials

US20050079187A1
(en)

2003-10-14
2005-04-14
Gardner Wallace J.
Composition, kit and method for reducing plaque formation, tooth decay and incidence of caries

LT2351555T
(en)

2004-02-23
2016-12-27
Euro-Celtique S.A.
Abuse resistance opioid transdermal delivery device

US8907153B2
(en)

2004-06-07
2014-12-09
Nuvo Research Inc.
Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same

US20080019927A1
(en)

2004-06-07
2008-01-24
Jie Zhang
Compositions and methods for dermally treating neuropathy with minoxidil

US20070196452A1
(en)

2004-06-07
2007-08-23
Jie Zhang
Flux-enabling compositions and methods for dermal delivery of drugs

US20070196325A1
(en)

2004-06-07
2007-08-23
Jie Zhang
Compositions and methods for dermally treating infections

US20070189978A1
(en)

2004-06-07
2007-08-16
Jie Zhang
Compositions and methods for dermally treating musculoskeletal pain

US20070190124A1
(en)

2004-06-07
2007-08-16
Jie Zhang
Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs

US8741332B2
(en)

2004-06-07
2014-06-03
Nuvo Research Inc.
Compositions and methods for dermally treating neuropathic pain

US20070196457A1
(en)

2004-06-07
2007-08-23
Jie Zhang
Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs

US20070196323A1
(en)

2004-06-07
2007-08-23
Jie Zhang
Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs

US20070196453A1
(en)

2004-06-07
2007-08-23
Jie Zhang
Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs

US20070196293A1
(en)

2004-06-07
2007-08-23
Jie Zhang
Compositions and methods for treating photo damaged skin

US8741333B2
(en)

2004-06-07
2014-06-03
Nuvo Research Inc.
Compositions and methods for treating dermatitis or psoriasis

KR101351771B1
(en)

2004-09-17
2014-02-17
듀렉트 코퍼레이션
Sustained local anesthetic composition containing preferably a sugar ester such as SAIB

JP2008517927A
(en)

2004-10-21
2008-05-29
ユニバーシティーオブアイオワリサーチファンデーション

In situ controlled release drug delivery system

WO2006096893A2
(en)

2005-03-10
2006-09-14
Marx Management Cc
Dental barrier composition

WO2007002041A2
(en)

2005-06-21
2007-01-04
Foster Corporation
Drug-filled polymer films

US20070027105A1
(en)

2005-07-26
2007-02-01
Alza Corporation
Peroxide removal from drug delivery vehicle

PL2450041T3
(en)

2005-10-12
2019-02-28
Unimed Pharmaceuticals, Llc
Improved testosterone gel for use in the treatment of hypogonadism

US20070280972A1
(en)

2006-04-25
2007-12-06
Zars, Inc.
Adhesive solid gel-forming formulations for dermal drug delivery

CN101505769A
(en)

2006-06-30
2009-08-12
皮瑞缪生命科学有限公司
Herbal compositions for the treatment of diseases of the oral cavity

CA2677750A1
(en)

2006-11-03
2008-06-05
Durect Corporation
Transdermal delivery systems

CA2706658A1
(en)

2007-12-06
2009-06-18
Durect Corporation
Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic condition

MX2010010512A
(en)

2008-03-26
2010-11-09
Alltranz Inc
Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists.

US20090311335A1
(en)

2008-06-12
2009-12-17
Scott Jenkins
Combination of a triptan and an nsaid

GB0818473D0
(en)

2008-10-08
2008-11-12
Probio Nutraceuticals As
Composition

US20100260844A1
(en)

2008-11-03
2010-10-14
Scicinski Jan J
Oral pharmaceutical dosage forms

US10322954B2
(en)

2008-11-20
2019-06-18
Hydro Air Global, Llc
Antimicrobial device and materials for fluid treatment

US9012477B2
(en)

2009-01-06
2015-04-21
Nuvo Research Inc.
Method of treating neuropathic pain

US8481678B2
(en)

2009-03-30
2013-07-09
E I Du Pont De Nemours And Company
Peptide-based tooth whitening reagents

CN102834096A
(en)

2010-01-14
2012-12-19
卢福研究公司
Solid-forming local anesthetic formulations for pain control

DE102010033048A1
(en)

2010-08-02
2012-02-02
Katz Biotech Ag

Use of a microencapsulated food substrate

US20140205662A1
(en)

2010-11-05
2014-07-24
The Research Foundation For The State University Of New York
System and method for differentially timed local delivery of a combination pharmaceutical preparation for oral therapy

US9452135B2
(en)

2012-03-20
2016-09-27
Particle Dynamics International, Llc
Gelling agent-based dosage form

US20150044147A1
(en)

2013-02-18
2015-02-12
King Abdullah International Medical Research Center
Composition for management of periodontal disease

BR112015022025A8
(en)

2013-03-14
2019-12-10
Hallux Inc

composition and use of an active agent

TW201521769A
(en)

2013-03-15
2015-06-16
Durect Corp
Compositions with a rheological modifier to reduce dissolution variability

CN104784152B
(en)

2014-01-20
2017-10-24
洛阳惠中兽药有限公司
A kind of Thiamphenicol micro-capsule and preparation method and application

DE102016101280A1
(en)

2016-01-26
2017-07-27
Frank Bröseler

Pharmaceutical composition

CN108498854B
(en)

2018-04-27
2021-06-15
温州医科大学附属第二医院（温州医科大学附属育英儿童医院）
Expanded sponge loaded with nano slow-release drug micelles and silver-loaded microspheres and preparation method and application thereof

WO2020211859A1
(en)

2019-04-18
2020-10-22
Board Of Regents Of The University Of Nebraska
Hydrogel drug delivery composition

KR20220140711A
(en)

2020-01-13
2022-10-18
듀렉트 코퍼레이션

Reduced Impurity Sustained Release Drug Delivery Systems and Related Methods

Family Cites Families (24)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US3185625A
(en)

1961-11-08
1965-05-25
Brown Ethan Allan
Injectionable substances

US3934001A
(en)

1965-12-07
1976-01-20
Lever Brothers Company
Oral compositions containing germicidally active plastic powders

FR2077696B1
(en)

1970-02-06
1973-03-16
Synthelabo

US4039653A
(en)

1974-01-23
1977-08-02
Defoney, Brenman, Mayes & Baron
Long-acting articles for oral delivery and process

JPS5138412A
(en)

1974-09-24
1976-03-31
Nippon Kayaku Kk
Kokoseizai no seiho

US3972995A
(en)

1975-04-14
1976-08-03
American Home Products Corporation
Dosage form

US4188373A
(en)

1976-02-26
1980-02-12
Cooper Laboratories, Inc.
Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes

US4138477A
(en)

1976-05-28
1979-02-06
Colgate Palmolive Company
Composition to control mouth odor

US4585651A
(en)

1978-10-17
1986-04-29
Stolle Research & Development Corporation
Active/passive immunization of the internal female reproductive organs

GB2042888B
(en)

1979-03-05
1983-09-28
Teijin Ltd
Preparation for administration to the mucosa of the oral or nasal cavity

US4292028A
(en)

1979-07-13
1981-09-29
Arthur Barr
Cosmetic breath freshener and palate coolant composition and method of use

US4622244A
(en)

1979-09-04
1986-11-11
The Washington University
Process for preparation of microcapsules

US4369172A
(en)

1981-12-18
1983-01-18
Forest Laboratories Inc.
Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose

US4434153A
(en)

1982-03-22
1984-02-28
Alza Corporation
Drug delivery system comprising a reservoir containing a plurality of tiny pills

SE8203953D0
(en)

1982-06-24
1982-06-24
Astra Laekemedel Ab

PHARMACEUTICAL MIXTURE

US4568535A
(en)

1982-08-06
1986-02-04
Loesche Walter J
Composition for periodontal administration

US4597960A
(en)

1983-04-19
1986-07-01
Cohen Edgar C
Microencapsulated astringent hemostatic agents and methods of use

CA1224148A
(en)

1983-05-16
1987-07-14
John L. Haslam
Drug delivery system utilizing thermosetting gels

JPS59222406A
(en)

1983-06-01
1984-12-14
Teijin Ltd
Pharmaceutical preparation for remedying periodontosis and its preparation

JPS60100516A
(en)

1983-11-04
1985-06-04
Takeda Chem Ind Ltd
Preparation of sustained release microcapsule

US4568538A
(en)

1984-02-23
1986-02-04
International Flavors & Fragrances Inc.
Flavoring with norbornyl pyridine derivatives

US4568536A
(en)

1985-02-08
1986-02-04
Ethicon, Inc.
Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition

US4650665A
(en)

1985-02-08
1987-03-17
Ethicon, Inc.
Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition

JPS62223112A
(en)

1986-03-25
1987-10-01
Rooto Seiyaku Kk
Remedy for periodontosis

1986

1986-04-29
US
US06/856,961
patent/US4780320A/en
not_active
Expired – Fee Related

1987

1987-04-10
NZ
NZ219948A
patent/NZ219948A/en
unknown

1987-04-14
DE
DE87303275T
patent/DE3787829T2/en
not_active
Expired – Fee Related

1987-04-14
EP
EP87303275A
patent/EP0244118B1/en
not_active
Revoked

1987-04-27
AU
AU72112/87A
patent/AU614061B2/en
not_active
Ceased

1987-04-28
NO
NO871774A
patent/NO177125C/en
unknown

1987-04-28
CA
CA000535738A
patent/CA1309345C/en
not_active
Expired – Fee Related

1987-04-28
MX
MX006257A
patent/MX167175B/en
unknown

1987-04-29
DK
DK219287A
patent/DK219287A/en
not_active
Application Discontinuation

1987-04-30
JP
JP62107935A
patent/JP2698353B2/en
not_active
Expired – Lifetime

Also Published As

Publication number
Publication date

EP0244118A1
(en)

1987-11-04

NO871774D0
(en)

1987-04-28

NO177125B
(en)

1995-04-18

NZ219948A
(en)

1988-11-29

DE3787829T2
(en)

1994-05-11

US4780320A
(en)

1988-10-25

CA1309345C
(en)

1992-10-27

DK219287A
(en)

1987-10-30

JPS6327422A
(en)

1988-02-05

DE3787829D1
(en)

1993-11-25

NO871774L
(en)

1987-10-30

NO177125C
(en)

1995-07-26

EP0244118B1
(en)

1993-10-20

DK219287D0
(en)

1987-04-29

JP2698353B2
(en)

1998-01-19

AU614061B2
(en)

1991-08-22

MX167175B
(en)

1993-03-08

Información de contacto